These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
132 related articles for article (PubMed ID: 38115179)
1. KLK10 promotes the progression of KRAS mutant colorectal cancer via PAR1-PDK1-AKT signaling pathway. Wu K; Wu B; Yan K; Ding Q; Miao Z Cell Biol Int; 2024 Apr; 48(4):440-449. PubMed ID: 38115179 [TBL] [Abstract][Full Text] [Related]
2. Kallikrein-related peptidase (KLK10) cessation blunts colorectal cancer cell growth and glucose metabolism by regulating the PI3K/Akt/mTOR pathway. Wei H; Dong C; Shen Z Neoplasma; 2020 Jul; 67(4):889-897. PubMed ID: 32386481 [TBL] [Abstract][Full Text] [Related]
3. Selective PI3Kδ inhibitor TYM-3-98 suppresses AKT/mTOR/SREBP1-mediated lipogenesis and promotes ferroptosis in KRAS-mutant colorectal cancer. Zheng YN; Lou SY; Lu J; Zheng FL; Tang YM; Zhang EJ; Cui SL; Zhao HJ Cell Death Dis; 2024 Jul; 15(7):474. PubMed ID: 38956060 [TBL] [Abstract][Full Text] [Related]
4. 4-Acetyl-Antroquinonol B Improves the Sensitization of Cetuximab on Both Kras Mutant and Wild Type Colorectal Cancer by Modulating the Expression of Ras/Raf/miR-193a-3p Signaling Axis. Chu YC; Tsai TY; Yadav VK; Deng L; Huang CC; Tzeng YM; Yeh CT; Chen MY Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299137 [TBL] [Abstract][Full Text] [Related]
5. NES1/KLK10 promotes trastuzumab resistance via activation of PI3K/AKT signaling pathway in gastric cancer. Tang L; Long Z; Zhao N; Feng G; Guo X; Yu M J Cell Biochem; 2018 Aug; 119(8):6398-6407. PubMed ID: 29231994 [TBL] [Abstract][Full Text] [Related]
6. Andrographolide sensitizes KRAS-mutant colorectal cancer cells to cetuximab by inhibiting the EGFR/AKT and PDGFRβ/AKT signaling pathways. Liu YF; Feng ZQ; Chu TH; Yi B; Liu J; Yu H; Xue J; Wang YJ; Zhang CZ Phytomedicine; 2024 Apr; 126():155462. PubMed ID: 38394734 [TBL] [Abstract][Full Text] [Related]
7. 3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner. Gagliardi PA; di Blasio L; Orso F; Seano G; Sessa R; Taverna D; Bussolino F; Primo L Neoplasia; 2012 Aug; 14(8):719-31. PubMed ID: 22952425 [TBL] [Abstract][Full Text] [Related]
8. Promising Therapeutic Efficacy of GC1118, an Anti-EGFR Antibody, against KRAS Mutation-Driven Colorectal Cancer Patient-Derived Xenografts. Lee HW; Son E; Lee K; Lee Y; Kim Y; Lee JC; Lim Y; Hur M; Kim D; Nam DH Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31771279 [TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA SNHG14 accelerates cell proliferation, migration, invasion and suppresses apoptosis in colorectal cancer cells by targeting miR-944/KRAS axis through PI3K/AKT pathway. Pei Q; Liu GS; Li HP; Zhang Y; Xu XC; Gao H; Zhang W; Li T Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9871-9881. PubMed ID: 31799655 [TBL] [Abstract][Full Text] [Related]
10. Concomitant inhibition of receptor tyrosine kinases and downstream AKT synergistically inhibited growth of KRAS/BRAF mutant colorectal cancer cells. Song Q; Sun X; Guo H; Yu Q Oncotarget; 2017 Jan; 8(3):5003-5015. PubMed ID: 28002807 [TBL] [Abstract][Full Text] [Related]
11. p53-armed oncolytic adenovirus induces autophagy and apoptosis in KRAS and BRAF-mutant colorectal cancer cells. Tamura S; Tazawa H; Hori N; Li Y; Yamada M; Kikuchi S; Kuroda S; Urata Y; Kagawa S; Fujiwara T PLoS One; 2023; 18(11):e0294491. PubMed ID: 37972012 [TBL] [Abstract][Full Text] [Related]
12. SLC25A22 Promotes Proliferation and Survival of Colorectal Cancer Cells With KRAS Mutations and Xenograft Tumor Progression in Mice via Intracellular Synthesis of Aspartate. Wong CC; Qian Y; Li X; Xu J; Kang W; Tong JH; To KF; Jin Y; Li W; Chen H; Go MY; Wu JL; Cheng KW; Ng SS; Sung JJ; Cai Z; Yu J Gastroenterology; 2016 Nov; 151(5):945-960.e6. PubMed ID: 27451147 [TBL] [Abstract][Full Text] [Related]
13. Pro-survival responses to the dual inhibition of anti-apoptotic Bcl-2 family proteins and mTOR-mediated signaling in hypoxic colorectal carcinoma cells. Risberg K; Redalen KR; Sønstevold L; Bjørnetrø T; Sølvernes J; Ree AH BMC Cancer; 2016 Jul; 16():531. PubMed ID: 27461218 [TBL] [Abstract][Full Text] [Related]
14. Relationships among Wan XB; Wang AQ; Cao J; Dong ZC; Li N; Yang S; Sun MM; Li Z; Luo SX World J Gastroenterol; 2019 Feb; 25(7):808-823. PubMed ID: 30809081 [TBL] [Abstract][Full Text] [Related]
15. Osthole inhibits malignant phenotypes and induces ferroptosis in KRAS-mutant colorectal cancer cells via suppressing AMPK/Akt signaling. Zhou X; Kang J; Zhang L; Cheng Y Cancer Chemother Pharmacol; 2023 Aug; 92(2):119-134. PubMed ID: 37318525 [TBL] [Abstract][Full Text] [Related]
16. Aberrant upregulation of KLK10 promotes metastasis via enhancement of EMT and FAK/SRC/ERK axis in PDAC. Cao XY; Zhang XX; Yang MW; Hu LP; Jiang SH; Tian GA; Zhu LL; Li Q; Sun YW; Zhang ZG Biochem Biophys Res Commun; 2018 May; 499(3):584-593. PubMed ID: 29621546 [TBL] [Abstract][Full Text] [Related]
17. Activated cMET and IGF1R-driven PI3K signaling predicts poor survival in colorectal cancers independent of KRAS mutational status. Lee J; Jain A; Kim P; Lee T; Kuller A; Princen F; In-GuDo ; Kim SH; Park JO; Park YS; Singh S; Kim HC PLoS One; 2014; 9(8):e103551. PubMed ID: 25090459 [TBL] [Abstract][Full Text] [Related]
18. Molecular Pathways Associated with Kallikrein 6 Overexpression in Colorectal Cancer. Pandey R; Zhou M; Chen Y; Darmoul D; Kisiel CC; Nfonsam VN; Ignatenko NA Genes (Basel); 2021 May; 12(5):. PubMed ID: 34065672 [TBL] [Abstract][Full Text] [Related]
19. LY3009120, a panRAF inhibitor, has significant anti-tumor activity in BRAF and KRAS mutant preclinical models of colorectal cancer. Vakana E; Pratt S; Blosser W; Dowless M; Simpson N; Yuan XJ; Jaken S; Manro J; Stephens J; Zhang Y; Huber L; Peng SB; Stancato LF Oncotarget; 2017 Feb; 8(6):9251-9266. PubMed ID: 27999210 [TBL] [Abstract][Full Text] [Related]
20. KLK8 promotes the proliferation and metastasis of colorectal cancer via the activation of EMT associated with PAR1. Hua Q; Sun Z; Liu Y; Shen X; Zhao W; Zhu X; Xu P Cell Death Dis; 2021 Sep; 12(10):860. PubMed ID: 34552064 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]